🇮🇳IN
Sign In
AC

ACCPL

NSE

ACCRETION PHARMA LIMITED

₹182.10

-7.20(-3.80%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

ACCPL valuation summary

ACCRETION PHARMA LIMITED trades at 21.3 times trailing earnings. Return on equity is 27.6% and return on capital employed is 28.9%.

P/E21.3
ROE27.6%
ROCE28.9%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer